IL6 and mastocytoma: These results demonstrate that alterations in a small population of transformed mastocytoma cells can cause systemic changes in the levels of serum IL-6, ROS and DJ-1 as mast cell burden progresses that resemble those described in Fig 1 for the groups of patients with mastocytosis.